Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | January 08, 2025 |
| PDB ID | UniProt ID ▼ | Title | Descriptor |
|---|---|---|---|
| 6OPQ | B3UEZ6 | CD4- and 17-bound HIV-1 Env B41 SOSIP frozen with LMNG | |
| 6CH9 | B3UEZ6 | Crystal structure of a natively-glycosylated B41 SOSIP.664 HIV-1 Envelope Trimer in complex with the broadly-neutralizing antibodies BG18 and 35O22 | |
| 6OPN | B3UEZ6 | CD4- and 17-bound HIV-1 Env B41 SOSIP in complex with small molecule GO35 | |
| 6OPP | B3UEZ6 | Asymmetric model of CD4- and 17-bound B41 HIV-1 Env SOSIP in complex with DDM | |
| 6X5B | B3UEZ6 | Symmetric model of CD4- and 17-bound B41 HIV-1 Env SOSIP in complex with small molecule GO52 | |
| 6X5C | B3UEZ6 | Asymmetric model of CD4-bound B41 HIV-1 Env SOSIP in complex with small molecule GO52 | |
| 5VN3 | B3UEZ6 | Cryo-EM model of B41 SOSIP.664 in complex with soluble CD4 (D1-D2) and fragment antigen binding variable domain of 17b | 17b Fab light chain, Envelope glycoprotein gp160, T-cell surface glycoprotein CD4, 17b Fab heavy chain |
| 5VN8 | B3UEZ6 | Cryo-EM model of B41 SOSIP.664 in complex with fragment antigen binding variable domain of b12 | Envelope glycoprotein gp160, b12 Fab heavy chain, b12 Fab light chain |
| 6EDU | B3UEZ6 | B41 SOSIP.664 in complex with soluble CD4 (D1-D2), the co-receptor mimicking antibody 21c and the broadly neutralizing antibody 8ANC195 | Envelope glycoprotein gp160, PG9 Fab heavy chain,PG9 Fab heavy chain, PG9 Fab light chain,PG9 Fab light chain, 8ANC195 Fab heavy chain,8ANC195 Fab heavy chain, 8ANC195 Fab light chain,8ANC195 Fab light chain |
| 6OKP | B3UEZ6 | B41 SOSIP.664 in complex with the silent-face antibody SF12 and V3-targeting antibody 10-1074 | |
| 6MUG | B3UEZ6 | Crystal Structure of HIV-1 B41 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-386150 in Complex with Human Antibodies 3H109L and 35O22 at 3.8 Angstrom | |
| 6OPO | B3UES2 | Symmetric model of CD4- and 17-bound B41 HIV-1 Env SOSIP in complex with DDM | |
| 6U59 | B3UES2 | HIV-1 B41 SOSIP.664 in complex with rabbit antibody 13B | |
| 6U59 | B3UES2 | HIV-1 B41 SOSIP.664 in complex with rabbit antibody 13B | |
| 6MDT | B3UES2 | Crystal structure of the B41 SOSIP.664 Env trimer with PGT124 and 35O22 Fabs, in P63 space group | |
| 6MUF | B3UES2 | Crystal Structure of HIV-1 B41 SOSIP.664 Prefusion Env Trimer in Complex with Human Antibodies 3H109L and 35O22 at 3.4 Angstrom | |
| 6OPQ | B3UES2 | CD4- and 17-bound HIV-1 Env B41 SOSIP frozen with LMNG | |
| 6CH9 | B3UES2 | Crystal structure of a natively-glycosylated B41 SOSIP.664 HIV-1 Envelope Trimer in complex with the broadly-neutralizing antibodies BG18 and 35O22 | |
| 6OPN | B3UES2 | CD4- and 17-bound HIV-1 Env B41 SOSIP in complex with small molecule GO35 | |
| 6OPP | B3UES2 | Asymmetric model of CD4- and 17-bound B41 HIV-1 Env SOSIP in complex with DDM | |
| 6X5B | B3UES2 | Symmetric model of CD4- and 17-bound B41 HIV-1 Env SOSIP in complex with small molecule GO52 | |
| 6X5C | B3UES2 | Asymmetric model of CD4-bound B41 HIV-1 Env SOSIP in complex with small molecule GO52 | |
| 5VN3 | B3UES2 | Cryo-EM model of B41 SOSIP.664 in complex with soluble CD4 (D1-D2) and fragment antigen binding variable domain of 17b | 17b Fab light chain, Envelope glycoprotein gp160, T-cell surface glycoprotein CD4, 17b Fab heavy chain |
| 5VN8 | B3UES2 | Cryo-EM model of B41 SOSIP.664 in complex with fragment antigen binding variable domain of b12 | Envelope glycoprotein gp160, b12 Fab heavy chain, b12 Fab light chain |
| 6EDU | B3UES2 | B41 SOSIP.664 in complex with soluble CD4 (D1-D2), the co-receptor mimicking antibody 21c and the broadly neutralizing antibody 8ANC195 | Envelope glycoprotein gp160, PG9 Fab heavy chain,PG9 Fab heavy chain, PG9 Fab light chain,PG9 Fab light chain, 8ANC195 Fab heavy chain,8ANC195 Fab heavy chain, 8ANC195 Fab light chain,8ANC195 Fab light chain |
| 6OKP | B3UES2 | B41 SOSIP.664 in complex with the silent-face antibody SF12 and V3-targeting antibody 10-1074 | |
| 6MCO | B3UES2 | Crystal structure of the B41 SOSIP.664 Env trimer with PGT124 and 35O22 Fabs, in P23 space group | |
| 6MUG | B3UES2 | Crystal Structure of HIV-1 B41 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-386150 in Complex with Human Antibodies 3H109L and 35O22 at 3.8 Angstrom | |
| 4H04 | B3TLD6 | Lacto-N-biosidase from Bifidobacterium bifidum | |
| 4JAW | B3TLD6 | Crystal Structure of Lacto-N-Biosidase from Bifidobacterium bifidum complexed with LNB-thiazoline | |
| 5BXP | B3TLD6 | LNBase in complex with LNB-LOGNAc | |
| 5BXR | B3TLD6 | LNBase in complex with LNB-NHAcDNJ | |
| 5BXS | B3TLD6 | LNBase in complex with LNB-NHAcCAS | |
| 5BXT | B3TLD6 | LNBase in complex with LNB-NHAcAUS | |
| 5FKS | B3PKK9 | Unraveling the first step of xyloglucan degradation by the soil saprophyte Cellvibrio japonicus through the functional and structural characterization of a potent GH74 endo-xyloglucanase | |
| 4CD4 | B3PGI1 | The structure of GH26 beta-mannanase CjMan26C from Cellvibrio japonicus in complex with ManIFG | |
| 4CD5 | B3PGI1 | The structure of GH26 beta-mannanase CjMan26C from Cellvibrio japonicus in complex with ManMIm | |
| 8BQB | B3PF55 | CjCel5C endo-glucanase bound to CB396 covalent inhibitor | |
| 4B9Z | B3PEE6 | Crystal Structure of Agd31B, alpha-transglucosylase, complexed with Acarbose | |
| 4BA0 | B3PEE6 | Crystal Structure of Agd31B, alpha-transglucosylase, complexed with 5F-alpha-GlcF | |
| 3QEF | B3PD60 | The structure and function of an arabinan-specific alpha-1,2-arabinofuranosidase identified from screening the activities of bacterial GH43 glycoside hydrolases | |
| 6HA9 | B3PD52 | Structure of an endo-Xyloglucanase from Cellvibrio japonicus complexed with XXXG(2F)-beta-DNP | |
| 5OYD | B3PD52 | GH5 endo-xyloglucanase from Cellvibrio japonicus | |
| 5OYE | B3PD52 | GH5 endo-xyloglucanase from Cellvibrio japonicus | |
| 6HAA | B3PD52 | Structure of a covalent complex of endo-Xyloglucanase from Cellvibrio japonicus after reacting with XXXG(2F)-beta-DNP | |
| 8OZ1 | B3PD52 | CjCel5D endo-xyloglucanase bounc to CB665 covalent inhibitor | |
| 8BQA | B3PCS3 | CjCel5B endo-glucanase bound to CB665 covalent inhibitor | |
| 2WHM | B3PBK3 | Cellvibrio japonicus Man26A E121A and E320G double mutant in complex with mannobiose | |
| 2XVK | B3PBD9 | crystal structure of alpha-xylosidase (GH31) from Cellvibrio japonicus in complex with 5-fluoro-alpha-D-xylopyranosyl fluoride | |
| 5IUE | B3KUD8 | Human leukocyte antigen F (HLA-F) presents peptides and regulates immunity through interactions with NK-cell receptors |
